RX Only: See important safety information about Suboxone
A Quick, Free Call
Your First Appointment
Suboxone, the Same Day
Enrollment Hours
8:00am - 9:00pm CST
Milwaukee County consistently accounts for a disproportionate share of Wisconsin’s opioid-related deaths. In 2020, Milwaukee County reported 415 overdose deaths, accounting for over one-third of Wisconsin’s total opioid deaths (1,227). The county’s overdose death rate increased by 30% from 2019 to 2020.
Milwaukee has more medication-assisted treatment (MAT) clinics compared to rural counties in the state. However, high overdose rates suggest that treatment availability may not be keeping pace with the crisis.
Milwaukee’s response to the opioid crisis includes interventions and prevention strategies aimed at reducing overdose deaths and addressing underlying factors contributing to substance abuse. These efforts involve collaboration between government agencies, healthcare providers, and community organizations.
Key Statistics on Opioid Use in Milwaukee
- Milwaukee County reported 415 overdose deaths in 2020, the highest in the state.
- Milwaukee’s overdose death rate (67.5 per 100,000 in 2020) is one of the highest in the U.S.
- In 2021 and 2022, 80% of all fatal overdoses in Milwaukee County involved opioids.
- In 2022, 81% of overdose deaths were fentanyl-related, up from 52% in 2018.
- The statewide Native American overdose death rate in Wisconsin was 80.4 per 100,000 in 2021.
- In 2020 alone, there were more than 7,000 treatment admissions for opioid addiction in Milwaukee.
Opioid Overdose Statistics in Milwaukee
- In 2022, there were 644 confirmed drug overdose deaths in Milwaukee County. This marks a potential fourth consecutive year of record-high drug overdose deaths.
- In 2021 and 2022, fentanyl was involved in 80% of all fatal overdoses in the county.
- Milwaukee County’s overdose death rate of 67.5 per 100,000 in 2020 was more than double the rate for the rest of Wisconsin, highlighting the severity of the urban opioid crisis.
Demographic Data & Insights
- In early 2021, overdose victims were diverse: 55% white, 29% Black, and 13% Hispanic, with small percentages of other racial groups. This distribution roughly mirrors the county’s overall population demographics, suggesting that the opioid crisis affects all communities in the area.
- Native Americans had the highest fatal overdose rate at 295 per 100,000 people in 2022. This rate is more than double that of the next highest group, Black Milwaukeeans.
- Caucasian patients received medication for opioid use disorder (OUD) up to 80% more often than Black patients and up to 25% more often than Hispanic patients.
- Overdose deaths among adolescents (ages 10-19) increased by 109% from late 2019 to late 2021, with 84% involving illicitly manufactured fentanyl.
- Substance abuse, particularly involving opioids like fentanyl, is the leading cause of death among people experiencing homelessness in Milwaukee County.
Common Opioids & Prescribing Trends
- While many rural areas across the country have high opioid prescribing rates, major urban districts like Milwaukee often display rates below the national average.
- Buprenorphine, illicit heroin, and fentanyl/analogs caused 84% of opioid deaths in recent years, indicating a shift from prescription opioid abuse to more dangerous street drugs.
- Fentanyl has emerged as the primary culprit in Milwaukee’s opioid epidemic. In 2022, fentanyl was involved in 78% of overdose deaths in Milwaukee County.
- Health officials have reported a rising presence of xylazine, a veterinary sedative, mixed with opioids. This combination increases the risk of overdose and complicates treatment efforts.
State Funds & Resource Allocation
- Milwaukee County continues to allocate resources and implement new programs, focusing on expanding access to evidence-based treatments and addressing the complex needs of individuals struggling with opioid addiction.
- The county expects to receive $70 million as its share of the state’s opioid settlement. This funding will be used to implement strategies such as expanding access to treatment and recovery, as well as supporting harm-reduction efforts.
- Milwaukee County allocated $19.7 million from opioid settlement funds for prevention and treatment programs.
- Over $2 million has been allocated to the Milwaukee County Medical Examiner’s Office for staffing and supplies.
- Wisconsin Department of Health Services offers grants for prevention, harm reduction, treatment, and recovery programs.
Resources & Support Groups in Milwaukee
- Community-based efforts like the Milwaukee Community Opioid Prevention Effort (COPE) are working to raise awareness and provide resources.
- Website: https://mkecope.wordpress.com/
- Milwaukee Overdose Response Initiative
- MORI, created in 2029, is a partnership between the Milwaukee Fire Department, Milwaukee Health Department, and community organizations.
- It provides immediate support to overdose survivors and connects people with treatment and recovery services.
- MORI aims to reach 100% of non-fatal opioid overdose patients who have had contact with Milwaukee EMS.
- Milwaukee Women’s Center
- This organization provides no-cost treatment and services for women struggling with substance abuse.
- Phone: 414-270-4600
Frequently Asked Questions
If you do not have insurance, the cost can vary based on the prescribed dose. Patients unable to afford buprenorphine/naloxone (Suboxone) (regardless of insurance coverage) can apply for cost-assistance. The company that makes Suboxone offers this type of program to help reduce out-of-pocket expenses. To learn more, go to: inSupport program.
You can also get discounted buprenorphine/naloxone (Suboxone) using pharmacy coupons or cash prizes. If you go to the GoodRx website (goodrx.com), you can enter in your zip code and find coupons and discounts at your pharmacy of choice. (On average, if you use GoodRx coupons/discounts, you can slash the typical price of generic Suboxone film from $395 to $118).
Before you are prescribed buprenorphine/naloxone (Suboxone), you will need to undergo an initial medical evaluation so that the doctor can ensure that it is an appropriate medication for you, though this does not require an in-person visit and can be done via telehealth (with video or telephone).
Once you have completed this assessment, the doctor will send a prescription to your preferred pharmacy. So, yes! You can find a licensed buprenorphine/naloxone (Suboxone) provider online and they can get you started on it via telehealth services without any in-person appointments.
- Buprenorphine/naloxone (Subxone) which is available in outpatient clinics (at your primary care doctor’s office or a psychiatrist’s office)
- Naloxone (Vivitrol) which is available in outpatient clinics (at your primary care doctor’s office or a psychiatrist’s office)
- Methadone, which is available only through methadone clinics
If you are interested in Buprenorphine/naloxone (Suboxone) offered entirely through telehealth services, visit bicyclehealth.com. To get help on finding other treatment options and levels of care (such as inpatient programs, intensive outpatient programs/IOPs, residential programs, and methadone clinics), call the SAMHSA helpline at:
1-800-662-HELP (4357).